These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7830067)

  • 81. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis.
    Viglio S; Marchi E; Wisniewski K; Casado B; Cetta G; Iadarola P
    Electrophoresis; 2001 Jul; 22(11):2343-50. PubMed ID: 11504071
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.
    Uusi-Rauva K; Blom T; von Schantz-Fant C; Blom T; Jalanko A; Kyttälä A
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468312
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Altered mitochondrial function in canine ceroid-lipofuscinosis.
    Siakotos AN; Blair PS; Savill JD; Katz ML
    Neurochem Res; 1998 Jul; 23(7):983-9. PubMed ID: 9690741
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Neuronal ceroid lipofuscinosis. Closing chapter of a long story].
    Elleder M
    Cesk Patol; 2000 May; 36(2):43-59. PubMed ID: 10916928
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations.
    Wisneiwski KE; Kida E; Patxot OF; Connell F
    Am J Med Genet; 1992 Feb; 42(4):525-32. PubMed ID: 1319116
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Altered levels of high-energy phosphate compounds in fibroblasts from different forms of neuronal ceroid lipofuscinoses: further evidence for mitochondrial involvement.
    Das AM; von Harlem R; Feist M; Lücke T; Kohlschütter A
    Eur J Paediatr Neurol; 2001; 5 Suppl A():143-6. PubMed ID: 11588986
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease).
    Jolly RD; Brown S; Das AM; Walkley SU
    Neurochem Int; 2002 May; 40(6):565-71. PubMed ID: 11850114
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Batten disease and the control of the Fo subunit c pore by cGMP and calcium.
    McGeoch JE; Guidotti G
    Eur J Paediatr Neurol; 2001; 5 Suppl A():147-50. PubMed ID: 11588987
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dolichyl-pyrophosphoryloligosaccharide protein oligosaccharide transferase in neuronal ceroid-lipofuscinosis.
    Van Dessel G; Lagrou A; Hilderson H; Dierick W
    Biochem Cell Biol; 1992 Jun; 70(6):515-8. PubMed ID: 1449718
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Regulation of the mitochondrial ATP-synthase in health and disease.
    Das AM
    Mol Genet Metab; 2003 Jun; 79(2):71-82. PubMed ID: 12809636
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Congenital ovine neuronal ceroid lipofuscinosis--a cathepsin D deficiency with increased levels of the inactive enzyme.
    Tyynelä J; Sohar I; Sleat DE; Gin RM; Donnelly RJ; Baumann M; Haltia M; Lobel P
    Eur J Paediatr Neurol; 2001; 5 Suppl A():43-5. PubMed ID: 11589006
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Electrospray ionisation mass spectrometry (ESI/MS) of ceroid lipofuscin protein; a model system for the study of F0 inhibitor interactions with mitochondrial subunit C.
    Ryan EM; Buzy A; Griffiths DE; Jennings KR; Palmer DN
    Biochem Soc Trans; 1996 May; 24(2):289S. PubMed ID: 8736947
    [No Abstract]   [Full Text] [Related]  

  • 96. Dysregulation of the mitochondrial ATP-synthase in respiratory chain defects: first experience.
    Das AM; Ullrich K
    J Inherit Metab Dis; 1998 Jun; 21(3):220-3. PubMed ID: 9686361
    [No Abstract]   [Full Text] [Related]  

  • 97. Cellular models of Batten disease.
    Minnis CJ; Thornton CD; FitzPatrick LM; McKay TR
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165559. PubMed ID: 31655107
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Glial fibrillary acidic protein is elevated in the lysosomal storage disease classical late-infantile neuronal ceroid lipofuscinosis, but is not a component of the storage material.
    Xu S; Sleat DE; Jadot M; Lobel P
    Biochem J; 2010 May; 428(3):355-62. PubMed ID: 20370715
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Biological effects of deuteronation: ATP synthase as an example.
    Olgun A
    Theor Biol Med Model; 2007 Feb; 4():9. PubMed ID: 17316427
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses.
    Ezaki J; Kominami E
    Brain Pathol; 2004 Jan; 14(1):77-85. PubMed ID: 14997940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.